Patents by Inventor David Agorku

David Agorku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Depletion of mouse cells for isolation of human cells
    Patent number: 10012647
    Abstract: A process for depleting host cells from a xenograft of human cells on a murine host is disclosed. The process includes fragmenting the xenograft, subjecting the sample to antibodies specific for a murine CD9 epitope coupled to a detection means, depleting the cell suspension from cells bound by the CD9-antibodies using the detection means, and collecting the cells not bound by the CD9-antibodies as target cells.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: July 3, 2018
    Assignee: Miltenyi Biotec, GmbH
    Inventors: Andreas Bosio, Olaf Hardt, David Agorku
  • DEPLETION OF MOUSE CELLS FOR ISOLATION OF HUMAN CELLS
    Publication number: 20160047808
    Abstract: Object of the invention is a process for depleting host cells from a xenograft of human cells on a murine host characterized in a) fragmenting the xenograft into a sample comprising a single cell suspension b) subjecting the sample to antibodies specific for a murine CD9 epitope coupled to a detection means c) depleting the cell suspension from cells bound by the CD9-antibodies using the detection means d) collecting the cells not bound by the CD9-antibodies as target cells.
    Type: Application
    Filed: July 15, 2015
    Publication date: February 18, 2016
    Applicant: Miltenyi Biotec GmbH
    Inventors: Andreas Bosio, Olaf Hardt, David Agorku